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We investigated whether metalloproteinase-9 (MMP-9) values in induced sputum (IS) and pulmonary function tests can serve as
a marker of damage and intensity of exposure to hazardous dust. Thirty-nine factory employees (28 workers exposed to metal par-
ticles and 11 supposedly nonexposed oﬃce workers) underwent IS induction. Samples were processed by conventional methods
within 2hours. The proportion of particles with diameters of 0–2μ in IS samples was signiﬁcantly higher in nonexposed than ex-
posed workers and in smoker compared to nonsmoker workers. MMP-9 and TIMP-1 levels were similar for both groups. A linear
regression model for MMP-9 based on exposure, smoking habits, and proportion of particles < 5μ revealed a positive correlation
between each of the explanatory variables and MMP-9 values. MMP-9 may serve as a marker for pulmonary injury.
Copyright © 2006 Yehuda Lerman et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Inhalation of certain types of inorganic dust can be associ-
ated with reversible pulmonary inﬂammation as well as the
induction of an irreversible inﬂammatory and ﬁbrotic lung
response. Somemediators,suchascytokinesandgrowthfac-
tors, have been implicated in pulmonary inﬂammation char-
acterized by the recruitment of inﬂammatory cells into the
alveolar compartment [1–3]. The airways are ultimately sub-
jected to a prolonged chronic inﬂammatory state that leads
to a number of structural abnormalities. We selected matrix
metalloproteinases (MMPs) as markers for this state inso-
far as they are key enzymes involved in extracellular matrix
(ECM) degradation in physiological and pathological condi-
tions.
M M P sc o n s i s to fan u m b e ro fs t r u c t u r a l l yr e l a t e de n -
zymes capable of digesting ECM and basement membrane
components [4]. The gelatinases MMP-2 and MMP-9 have
a substrate aﬃnity for basement membrane type IV colla-
gen, denatured collagens (gelatin), and elastin. The tissue in-
hibitors of metalloproteinases (TIMPs) comprise a family of
which four members have thus far been identiﬁed: they form
complexeswithactiveenzymesandinhibitMMPactivity[5].
We recently reported that IS may reveal the status of haz-
ardous dust exposure (silica and hard metals) as eﬀectively
as bronchoalveolar lavage (BAL) [6]. BAL and IS specimens
among silica and hard metal workers yielded similar quanti-
tativeandqualitativeresultsinmeannumbersandsizedistri-
bution of particles present in samples and chemical analysis
of the retrieved particles. In a subsequent study, we demon-
strated that distribution of particles size in IS specimens was
diﬀerentbetweenexposedandnonexposedworkers,andthat
there was a correlation between the distribution of particle
size and the results of these workers’ pulmonary function
tests [7]. We also showed that metalloproteinase-9 (MMP-9)
is elevated in the IS of patients with granulomatous diseases
[8].
In the present study, we evaluated the inﬂammatory role
of MMP-9 in the airways of workers directly exposed to haz-
ardous dust in order to detect occult pulmonary pathology.
We compared our ﬁndings to those of a group of workers in
oﬃces of the same plant and whom we assumed were not
similarly exposed to these particles.
METHODS
Studypopulation
Twenty-eight male employees in a steel production factory
volunteered to participate in the study which was approved
by the Tel Aviv Sourasky Medical Center Ethics Committee.
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moldsbymelting,reﬁning,andpouringthemetalintomolds
andﬁnallyremovingalladherentsandandsuperﬂuousmetal
fromtheﬁnishedcasting.Themoldsweremadeofsilicasand
bound with clay. All of the subjects were actively employed
and exposed tosilica, chromiumferrum,nickel, and silicone.
Whatwehadconsideredasbeinga“nonexposed”groupcon-
sisted of 11 oﬃce workers in the same plant.
The respective range and median of exposure, as mea-
sured by environmental monitoring of airborne particles in
the factory, were 0.04–50.76mg/m3 and 4.1mg/m3 for iron
oxides (threshold limit value (TLV) = 5mg/m 3), 0.0009–
0.26mg/m3 and 0.032mg/m3 for chromium (TLV = 0.01
mg/m3), 0.0083–0.86mg/m3 and 0.076mg/m3 for nickel
(TLV = 0.2mg/m 3), 0.0074–0.84mg/m3 and 0.091mg/m3
for manganese (TLV = 0.2mg/m 3), 0.01–0.088mg/m3 and
0.028forrespirablefreecrystallinesilica (TLV = 0.1mg/m 3),
and 0.04–2.58mg/m3 and 0.29 for total free crystalline silica
(TLV = 0.3mg/m 3).
DataCollection
Each participant in the study ﬁlled in a questionnaire on de-
mographic and occupational parameters, smoking and alco-
hol consumption habits, a general health proﬁle, and symp-
toms and signs speciﬁc to respiratory problems.
Sputuminductionandprocessing
Sputum induction was performed at the workplace using a
slightly modiﬁed method of Pin et al [9], and the retrieved
material was brought to the laboratory for analysis within
two hours of induction, with no need for refrigeration. After
pretreatment with a short-acting beta-2 agonist, 3% saline
was administered by a nebulizer (U1 Ultrasonic Nebulizer,
Omron HealthCare, New Barn Lane, Henﬁeld West Sussex,
USA) for up to 20minutes while the subjects were encour-
aged to cough and expectorate sputum into a sterile con-
tainer. Samples were stored at 4◦C and processed within
3hours. All portions with little or no squamous epithe-
lial cells (rich nonsquamous epithelial cell fraction consid-
ered to originate from the lower respiratory tract, hereafter
referred to as “plugs”) were collected using the “selection
plug method” and processed as previously described [6, 10].
Brieﬂy, plugs were selected and treated with dithiothreitol
(DTT; Sputalysin, Calbiochem Corp, San Diego, Calif, USA).
The cell suspension was ﬁltered through a 52-μmn y l o n
gauze (BNSH Thompson, Scarborough, Ontario, Canada)
and the eﬀect of DTT was stopped by diluting the suspen-
sion with phosphate-buﬀered solution (PBS) to a volume
equal to the sputum plus DTT. After centrifugation, the su-
pernatants were deep frozen for consecutive measurement
of MMP-9. The pellets were resuspended and cytospinned
(Shandon Southern Instruments, Sewickley, Pa, USA), and
the slides were stained by Giemsa. Two-hundred nonsqua-
mous cells were counted, and the results were expressed as a
percentage of the total nonsquamous count. The slides were
read by two independent readers.
Quantitativeanalysis
Particle size analysis (PSA) and dynamic shape characteriza-
tion (DSC) were performed by employing a laser technique
based on the time of transition (TOT) theory [11] using a
CIS-1 Analyzer (Ankersmid-Yokneam, Israel). This method
allows an exact quantitative analysis to be obtained accord-
ing to particle size. The range diameter of the particles that
were measured was 0.5–10μm. Two drops of a suspension of
sputum cells (106 cells/ml) were introduced into a quartz cu-
vettecontainingstirredX3distilledwater.AHeNelaserbeam
crossed the particles suspension and the signal was registered
byaphotodiodeplaceddirectlybehindthem.Acontrolback-
groundwasobtainedwithX3distilledwaterwithnomeasur-
able particles.
For comparison of their sizes, we divided the particles
into four groups according to their diameters, that is, < 2μ,
> 2μ,b e t w e e n2 – 5μ,a n d> 5μ.
Spirometry
Spirometry was performed by a portable spirometer (Vital-
ograph-compact II, Buckingham, UK). Measurements fol-
lowed standard protocols according to the American Tho-
racic Society guidelines [12]. The best of three consecutive
measurements was chosen.
MMP-9andTIMP-1levels
The absolute value of MMP-9 in the IS samples was obtained
by enzyme-linked immunoabsorbent assay (ELISA, R & D
Systems Inc, Minn, USA). The normal range for MMP-9 is
0.17–0.39ng/ml and for TIMP-1 is 0–0.40ng/ml [8].
Statisticalanalysis
Comparisons between the groups of subjects (exposed ver-
sus nonexposed, smokers versus nonsmokers) with regard
to demographic and clinical factors were performed using
t-tests for independent samples, Mann-Whitney nonpara-
metric test, Chi-square and Fisher’s Exact tests, as applicable.
Pearson correlation coeﬃcients were calculated to study the
relationship between particle diameter size and spirometry
parameters in the entire sample and in each subgroup sepa-
rately, according to smoking habits and metals exposure. A
multiple linear regression analysis was performed to evaluate
the simultaneous eﬀect of smoking habits, extended expo-
sure, and proportions of particles on the inﬂammatory re-
sponse as measured by MMP-9. The assessment of goodness
of ﬁt of the model was done using R2. The statistical signif-
icance level was set to 0.05 and the SPSS for Windows soft-
ware, Version 12.0 was used for the analysis.
RESULTS
Comparison of the demographic, occupational and medi-
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Table 1: Demographic and occupational parameters of the study participants.
Exposed (n = 28) Nonexposed (n = 11) P-value∗ NS
Age (years) mean ±SD 47.6 ±10.95 1 .4 ±6.6—
Smokers (n) 22 4 0.022
Nonsmokers (n)6 7 —
E m p l o y m e n ta tt h ep r e s e n tw o r k p l a c e
< 10 years 55.0% 10.5% —
11–20 years 22.5% 31.6% —
> 20 years 22.5% 57.9% 0.003
NS: nonsigniﬁcant.
∗Nonparametric Mann-Whitney test. A P-value <. 05 was considered as indicative of a signiﬁcant statistical diﬀerence.
Table 2: A comparison of particles size, spirometry parameters, MMP-9, and diﬀerential cell counts between the exposed, nonexposed,
smoker, and nonsmoker groups.
Exposed n = 28 Nonexposed n = 11 Smokers n = 26 Nonsmokers n = 13
% Particles with a 0–2μ diameter 91.8 ±4.9∗ 95.9 ±5.2∗ 95.4 ± 5.2∗ 91.8 ±4.8∗
FVC(%) 91.9 ±10.68 9 .6 ±12.68 9 ±12.79 2 .9 ±10.6
FEV1/FVC 80.5 ±5.6∗ 85 ±.26.4∗ 84 ±7.38 3 . ±4.4
Neutrophils (%) 42.8 ±27.95 6 .4 ±27.86 1 ±22.63 7 .7 ±33.2
Lymph (%) 5.3 ±4.81 3 .8 ±23.14 .2 ±3.21 3 ±18
Macroph (%) 42.6 ± 30 35.9 ±27.73 2 ±22.64 8 .8 ±35.6
Eosinophils (%) 2.4 ±3.11 .3 ±0.8∗ 2.8 ±3.2∗ 0.5 ±1.41∗
MMP-9 (ng/ul) 1.5 ±1.51 .3 ±1.21 .6 ±1.41 .1 ± 0.65
TIMP-1 (ng/ul) 0.16 ±0.02 0.14 ±0.01 0.13 ±0.02 0.14 ± 0.03
MMP-9: metalloproteinase-9, TIMP-1: tissue inhibitor metalloproteinase, NS: nonsigniﬁcant.
∗Nonparametric Mann-Whitney test. A P-value <. 05 was considered as indicative of a signiﬁcant statistical diﬀerence.
groups showed no diﬀerences in age or in the presence of
symptomsandsignsofrespiratorydiseases.Thereweremore
smokers among the exposed workers (p = 0.022) who had
also worked for a shorter period of time in the plant than
among the nonexposed workers (p = 0.0030) (Table 1).
A comparison of the particle sizes between the exposed
and nonexposed groups revealed a signiﬁcant diﬀerence in
the proportion of particles with a diameter of 0–2μ:i tw a s
higher in the nonexposed workers (91.8±4.9% versus 95.9±
5.2%, resp, p = 0.03). Similar diﬀerences were found be-
tween particle sizes in smokers versus nonsmokers (95.4 ±
5.2% versus 91.8 ± 4.8%, resp, p = 0.05). Pulmonary func-
tion tests showed a signiﬁcant diﬀerence in the FEV1/FVC
ratio (lower in the nonexposed group, p = 0.035), but no
diﬀerence in the FVC and FEV1 parameters (Table 2).
A positive strong correlation was found between the se-
cretion of MMP-9 and TIMP-1 (r = 0.88; p = 0.0000) in all
measurements, but there were no diﬀerences in metabolite
secretion when groups were divided according to exposure.
The diﬀerential cell counts from IS samples showed a bor-
derlinediﬀerencebetweenexposedandnonexposedworkers,
but the diﬀerence was signiﬁcant between the smokers and
nonsmokers(2.8±3.2%insmokersversus0.5±1.4%innon-
smokers (p = 0.013). There were no signiﬁcant diﬀerences
in any of the other cell types (Table 2). Measurable levels of
M M P - 9a n dT I M P - 1w e r ed e t e c t e dm o r ei ns m o k e r ss a m -
ples than in nonsmokers samples (p = 0.046 and p = 0.035,
resp).
The associations between MMP-9 and particle diameter
size, pulmonary function tests and diﬀerential counts were
checked using the Pearson correlation, dividing the work-
ers according to length of exposure. Signiﬁcant correlations
were found only for the group of nonexposed workers: the
correlation was positive between the percentage eosinophils
and MMP-9 and negative between the PFT parameters and
MMP-9 (Table 3).
In order to check what are the other factors that could be
involved in inﬂammatory changes in nonexposed workers,
a second group of correlations was performed after dividing
theworkersaccordingtosmokingstatus(Table 3).Therewas
a positive correlation between percentage particles with a 0–
2μ diameter (r = 0.4, p = 0.08) and a negative signiﬁcant4 Mediators of Inﬂammation
Table 3: Correlation of diﬀerent parameters with MMP-9 (ng/ml) secretion among exposed and nonexposed workers.
Parameter MMP-9 (ng/ml)
Pearson correlation = r; signiﬁcance = p
Exposed (n = 28) Nonexposed (n = 11)
FEV1 (L) r = 0.1; p = 0.5 r =− 0.7; p = 0.016
FEV1/FVC r = 0.04; p = 0.8 r =− 0.8; p = 0.002
Eosinophils (% n = 26) r =− 0.4; p = 0.07 r = 0.8; p = 0.047
Smokers (n = 26) Nonsmokers (n = 13)
% Particles with a 0–2μ diameter r = 0.356; p = 0.08 r = 0.2; p = 0.1
% Particles with a ≤ 5μ diameter r =− 0.405; p = 0.05 r =− 0.13; p = 0.1
MMP-9: metalloproteinase-9.
A P-value <. 05 was considered as indicative of a signiﬁcant statistical diﬀerence.
Table 4: Linear regression model for MMP-9 based on exposure, smoking habits, and proportion of particles ≤ 5μ in diameter [total
R2 = 0.181, N = 36].
Parameter B (CI 95%) P-value R2
% particles with a ≤ 5μ diameter 0.27 (0.02, 0.53) 0.038 0.084
Smoking habits −0.86 (−1.75,0.38) 0.060 0.094
Exposure to metals 0.17 (−0.76,1.10) 0.713 0.003
Constant −24.25 (−49.1,0.60) — —
MMP-9: metalloproteinase-9.
correlation between particles > 5μ in diameter and MMP-9
levels in smokers (r = 0.4, p = 0.05).
A linear regression model for MMP-9 based on exposure,
smoking habits, and proportion of particles ≤ 5μ revealed a
positive correlation between each one of these explanatory
variables and MMP-9 (Model R-square = 0.18), although
the impact of exposure was not signiﬁcant (Table 4).
DISCUSSION
In the present work, we assessed 28 workers who were ex-
posed to airborne particles of silica and metals and 11 work-
ers in the administration oﬃces of the same plant: our ex-
pectation was that the latter would serve as a suitable con-
trol group. The results showed that our “control” group had
signiﬁcantly smaller particles in their IS samples, displayed
an inﬂammatory pattern as indicated by a higher percentage
of eosinophils in sputum and their FEV1/FVC values had a
signiﬁcant trend for lower ratios for obstructive and not re-
strictive disease as we had originally expected. The presence
of a higher percentage of small particles, even to an appar-
ently small degree, exerts a biological eﬀect by increasing the
level of eosinophils in sputum in correlation to physiological
changes. This unexpected ﬁnding might be explained by the
facts that the nonexposed workers were older and that most
of them had worked at the factory for longer than 10 years.
They had probably been indirectly exposed to dust at lower
levels than their coworkers and for a longer period of time,
which may underestimate the risks. It is known that there is
usually a long latency period between the start of exposure
and the appearance of clinical symptoms of an occupational
lung disease, ranging anywhere between 10–30 years [13].
The MMP-9 and TIMP-1 levels were similar between the
groups, but the picture became reversed when we compared
the smokers among them: the smokers in the exposed and
“control”grouphadmoreinﬂammatoryparameters,asindi-
cated by diﬀerential cell counts and MMP-9 measurements,
than all the nonsmokers. Consequently, our next step was to
assess the correlations of MMP-9 and TIMP-1 with exposure
between smokers and nonsmokers in the entire cohort. We
found a positive correlation between the inﬂammatory pa-
rameters, the percentage of small particles—and not the an-
ticipated large particles—in the IS samples of the smokers.
Our working hypothesis was that MMP-9 levels would
be elevated among workers exposed to mineral particles as a
marker of early events occurring in proﬁbrotic lesions. This
hypothesiswasbasedonthefactthatMMPsandTIMPswere
recentlyshowntoparticipateintheparenchymaldestruction
and repair processes resulting in ECM remodeling, and to be
involved with diﬀerent pulmonary processes associated with
the destruction of the subepithelial basement membrane, for
example, idiopathic interstitial pneumonias [14] and pul-
monary ﬁbrosis [15]. Moreover, MMP-9 was found to be
elevated in experimental lung silicosis [16] and in workersYehuda Lerman et al 5
exposedtotoluenediisocyanate[17].Theresultsweobtained
did not support our working hypothesis, but rather raised
the problematic issue of the exposure of workers who smoke
in terms of the combined eﬀect of smoking and occupational
exposure.
Themaincontributionofthepresentstudyisthedemon-
stration of what appears to be combined respiratory impair-
ment due to smoking and occupational/environmental ex-
posure among smoker workers. The levels of MMP-9 and
TIMP-1 could be mainly explained by their smoking status.
Indeed, a recent study investigated the release and activity of
MMP-9 and of TIMP-1 from alveolar macrophages obtained
from patients with COPD, and compared them with age
and smoking status-matched healthy smokers. The results
showed that alveolar macrophages are a signiﬁcant source of
MMP-9 in the airways of smokers subjects with COPD, and
that they were more active than MMP-9 released from alve-
olar macrophages of healthy smokers and nonsmoking sub-
jects [18].
Evidence from experimental models showed that the
combination of exposure to particles plus ozone, cigarette
smoke, or reagent hydrogen peroxide augments the inﬂam-
matoryresponse,increasescellproliferation,andleadstolib-
eration of increased levels of chemoattractant mediators. It
is also known that particulate matter adheres and penetrates
epithelial cells, that retention within the walls of small air-
ways is increased by cigarette smoke, and that long-term ex-
posure to high levels of ambient particulate pollutants is as-
sociated with small airway remodeling, even in nonsmokers
[19]. This potent mixture contained in cigarettes, therefore,
exhibitsmajoreﬀectsontheairwayandmaycontributetoal-
teration of the MMP/TIMP balance, a process that may pro-
duce chronic airﬂow obstruction [20]. We now report the as-
sociation of MMP-9 and TIMP-1 in IS in correlation to com-
bined particle burden from smoking and occupational expo-
sure in the work plant.
We concluded from the ﬁndings of this study that there is
aneedtoincludeallworkersinaplantinscreeningandmed-
icalfollow-upprograms,eventhosenotdirectlyrelatedtothe
manufacturingprocess.HavingshownthatMMP-9levelsare
high in apparently healthy exposed workers, we consider this
enzyme as representing an interesting compound that merits
further studies in other forms of pulmonary disease.
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